Franklin Resources Inc Guardant Health, Inc. Transaction History

Franklin Resources Inc

$356 Billion
Q2 2025

A detailed history of Franklin Resources Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 2,319,947 shares of GH stock, worth $154 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,319,947

Previous 1,301,803 78.21%

Holding current value

$154 Million

Previous $55.5 Million 117.7%

% of portfolio

0.03%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$37.05 - $52.04 $37.7 Million - $53 Million	1,018,144 Added 78.21%	2,319,947 $121 Million
Q1 2025 May 13, 2025	BUY	$31.77 - $49.94 $11.5 Million - $18.1 Million	361,757 Added 38.48%	1,301,803 $55.5 Million
Q4 2024 Feb 12, 2025	SELL	$20.2 - $38.11 $120,775 - $227,859	-5,979 Reduced 0.63%	940,046 $28.7 Million
Q3 2024 Nov 12, 2024	SELL	$22.3 - $36.29 $2.76 Million - $4.5 Million	-123,938 Reduced 11.58%	946,025 $21.7 Million
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $43,421 - $86,031	2,702 Added 0.25%	1,069,963 $30.9 Million
Q1 2024 May 13, 2024	SELL	$17.13 - $26.91 $5.17 Million - $8.12 Million	-301,748 Reduced 22.04%	1,067,261 $22 Million
Q4 2023 Feb 09, 2024	BUY	$21.58 - $29.5 $2.84 Million - $3.88 Million	131,646 Added 10.64%	1,369,009 $37 Million
Q3 2023 Nov 13, 2023	BUY	$25.8 - $39.97 $135,295 - $209,602	5,244 Added 0.43%	1,237,363 $36.7 Million
Q2 2023 Aug 11, 2023	BUY	$20.94 - $38.01 $671,231 - $1.22 Million	32,055 Added 2.67%	1,232,119 $44.1 Million
Q1 2023 May 12, 2023	SELL	$22.92 - $33.76 $11.5 Million - $16.9 Million	-500,130 Reduced 29.42%	1,200,064 $28.1 Million
Q4 2022 Feb 10, 2023	SELL	$25.44 - $59.78 $32.1 Million - $75.4 Million	-1,261,202 Reduced 42.59%	1,700,194 $46.2 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $8.38 Million - $11.7 Million	191,898 Added 6.93%	2,961,396 $159 Million
Q2 2022 Aug 11, 2022	BUY	$28.82 - $77.35 $4.55 Million - $12.2 Million	157,961 Added 6.05%	2,769,498 $112 Million
Q1 2022 May 13, 2022	BUY	$48.25 - $100.49 $59.3 Million - $124 Million	1,229,021 Added 88.9%	2,611,537 $173 Million
Q4 2021 Feb 11, 2022	SELL	$88.71 - $120.43 $32.8 Million - $44.5 Million	-369,428 Reduced 21.09%	1,382,516 $138 Million
Q3 2021 Nov 12, 2021	BUY	$98.77 - $132.17 $3.14 Million - $4.21 Million	31,819 Added 1.85%	1,751,944 $219 Million
Q2 2021 Aug 13, 2021	SELL	$109.77 - $165.68 $10 Million - $15.1 Million	-91,066 Reduced 5.03%	1,720,125 $214 Million
Q1 2021 May 13, 2021	BUY	$127.04 - $179.1 $24.3 Million - $34.3 Million	191,472 Added 11.82%	1,811,191 $276 Million
Q4 2020 Feb 10, 2021	BUY	$99.96 - $135.93 $29.4 Million - $39.9 Million	293,670 Added 22.15%	1,619,719 $209 Million
Q3 2020 Nov 12, 2020	BUY	$80.32 - $111.8 $34.5 Million - $48 Million	429,441 Added 47.9%	1,326,049 $148 Million
Q2 2020 Aug 13, 2020	SELL	$60.49 - $97.5 $1.38 Million - $2.22 Million	-22,816 Reduced 2.48%	896,608 $74.3 Million
Q1 2020 May 13, 2020	SELL	$59.04 - $88.81 $327,494 - $492,629	-5,547 Reduced 0.6%	919,424 $64 Million
Q4 2019 Feb 12, 2020	BUY	$59.49 - $82.78 $15.1 Million - $21 Million	254,288 Added 37.91%	924,971 $72.3 Million
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $7.02 Million - $12.4 Million	-112,089 Reduced 14.32%	670,683 $42.8 Million
Q2 2019 Aug 14, 2019	SELL	$63.94 - $91.11 $16.2 Million - $23.1 Million	-253,292 Reduced 24.45%	782,772 $67.6 Million
Q1 2019 May 14, 2019	SELL	$34.3 - $97.98 $6.31 Million - $18 Million	-183,884 Reduced 15.07%	1,036,064 $79.4 Million
Q4 2018 Feb 12, 2019	BUY	$29.2 - $46.1 $35.6 Million - $56.2 Million	1,219,948 New	1,219,948 $45.9 Million

Others Institutions Holding GH

# of Institutions

416

Shares Held

127M

Call Options Held

1.51M

Put Options Held

2.35M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $6.8B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Guardant Health, Inc. Transaction History